Antidepressant use is associated with an increased risk of head injuries and traumatic brain injuries among persons with Alzheimer’s disease, according to a new study...

The CPhI predictions foresaw advancement in QbD, continuous processing, and a dramatic rise in FDA warning letters Amsterdam, 27 July 2017: CPhI Worldwide, organized ...

Wedel (26. July 2017). Medac Gesellschaft für klinische Spezialpräparate mbH has announced that methotrexate has been approved for treatment of Crohn's disease with i...

Lenvatinib filing based on pivotal Phase III REFLECT study demonstrating non-inferior overall survival compared to sorafenib Simultaneous submissions to EMA and ...

Basel, Switzerland, July 17, 2017 – Two industry innovators are joining forces to take the lead in real-world studies. Clinerion and Cisiv have formed a groundbreakin...

NEWHOUSE, UK: BioAscent Discovery Limited has announced the appointment of Paul Smith as CEO, in preparation for the expansion of BioAscent’s discovery services offer...

Paris, July 12, 2017 - ABIVAX, an innovative biotechnology company targeting the immune system to eliminate viral diseases, today announced the publication of a paper...

Mechelen (Belgium), 12 July 2017 - Biocartis Group NV ('Biocartis' or the 'Company'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today an...

The 2017 awards include 8 new categories - celebrating outstanding achievements in the pharma industry Full list of categories: Excellence in Pharma: API Developme...

Paris (France) -  Onxeo S.A., a clinical-stage biotechnology company specializing in the development of innovative drugs for the treatment of orphan diseases, in part...